{"paper_id":"228a0d7d-5a5d-467a-b62c-dceffa780493","body_text":"Abstract\nIn a book on hysterectomy techniques a detailed evaluation of myomectomies has its stand as more than 30 % of hysterectomies are performed because of large or symptomatic fibroids.\nUterine fibroids are the most frequent benign tumors of the female genital tract. Fibroids are associated with a variety of clinical problems, e.g. pain and pressure symptoms, bleeding disorders, bulk-related symptoms or infertility. For women wishing to preserve their uterus, fibroids can be surgically removed by hysteroscopy, laparoscopy or laparotomy. While hysterectomy remains the only definitive solution, many alternative treatment possibilities for uterine preservation are available today. The indication for a specific treatment has to be taken carefully after considering alternative treatment methods, such as expectant management, medical treatment or interventional radiologic methods, and after obtaining informed consent from the patient. The optimal method of treatment takes into account the patient’s interests and wishes and the practical feasibility in the clinical setup. Surgical skills and experience play an important role as surgical procedures on the uterus are not without risk and can lead to severe complications. The decision to operate anticipates an improvement of the initial situation and, therefore, the ideal surgical approach is of utmost importance. Today, a sequence of laparoscopic and hysteroscopic surgical steps with adequate instrumentation and knowledge of suturing guarantees a satisfying surgical outcome of myomectomy if hysterectomy is not desired.\nAccess this chapter\nTax calculation will be finalised at checkout\nPurchases are for personal use only\nSimilar content being viewed by others\nReferences\nWatson JD, Crick FH. Molecular structure of nucleic acids; a structure for deoxyribose nucleic acid. Nature. 1953;171(4356):737–8.\nWatson JD, Crick FH. Genetical implications of the structure of deoxyribonucleic acid. Nature. 1953;171(4361):964–7.\nSpektrum der Wissenschaft.\nTreloar SA et al. Pathways to hysterectomy: insights from longitudinal twin research. Am J Obstet Gynecol. 1992;167(1):82–8.\nSnieder H, MacGregor AJ, Spector TD. Genes control the cessation of a woman’s reproductive life: a twin study of hysterectomy and age at menopause. J Clin Endocrinol Metab. 1998;83(6):1875–80.\nVikhlyaeva EM, Khodzhaeva ZS, Fantschenko ND. Familial predisposition to uterine leiomyomas. Int J Gynaecol Obstet. 1995;51(2):127–31.\nVan Voorhis BJ, Romitti PA, Jones MP. Family history as a risk factor for development of uterine leiomyomas. Results of a pilot study. J Reprod Med. 2002;47(8):663–9.\nAl-Hendy A, Salama SA. Catechol-O-methyltransferase polymorphism is associated with increased uterine leiomyoma risk in different ethnic groups. J Soc Gynecol Investig. 2006;13(2):136–44.\nTsibris JC et al. Insights from gene arrays on the development and growth regulation of uterine leiomyomata. Fertil Steril. 2002;78(1):114–21.\nWang H et al. Distinctive proliferative phase differences in gene expression in human myometrium and leiomyomata. Fertil Steril. 2003;80(2):266–76.\nGross K, Morton C, Stewart E. Finding genes for uterine fibroids. Obstet Gynecol. 2000;95(4 Suppl 1):60.\nPatterson-Keels LM et al. Morphologic assessment of endometrium overlying submucosal leiomyomas. J Reprod Med. 1994;39(8):579–84.\nFlynn M et al. Health care resource use for uterine fibroid tumors in the United States. Am J Obstet Gynecol. 2006;195(4):955–64.\nHartmann KE et al. Annual costs associated with diagnosis of uterine leiomyomata. Obstet Gynecol. 2006;108(4):930–7.\nPeddada SD et al. Growth of uterine leiomyomata among premenopausal black and white women. Proc Natl Acad Sci U S A. 2008;105(50):19887–92.\nLaughlin SK, Hartmann KE, Baird DD. Postpartum factors and natural fibroid regression. Am J Obstet Gynecol. 2011;204(6):496 e1–6.\nZaima A, Ash A. Fibroid in pregnancy: characteristics, complications, and management. Postgrad Med J. 2011;87(1034):819–28.\nMarjoribanks J, Lethaby A, Farquhar C. Surgery versus medical therapy for heavy menstrual bleeding. Cochrane Database Syst Rev. 2006;2:CD003855.\nAl-Hendy A et al. Gene therapy of uterine leiomyomas: adenovirus-mediated expression of dominant negative estrogen receptor inhibits tumor growth in nude mice. Am J Obstet Gynecol. 2004;191(5):1621–31.\nDonnez J et al. Ulipristal acetate versus placebo for fibroid treatment before surgery. N Engl J Med. 2012;366(5):409–20.\nDonnez J et al. Long-term treatment of uterine fibroids with ulipristal acetate. Fertil Steril. 2014;101(6):1565–73. e1–18.\nDonnez J et al. Efficacy and safety of repeated use of ulipristal acetate in uterine fibroids. Fertil Steril. 2015;103(2):519–27. e3.\nEdwards RD et al. Uterine-artery embolization versus surgery for symptomatic uterine fibroids. N Engl J Med. 2007;356(4):360–70.\nvan der Kooij SM et al. Uterine artery embolization versus surgery in the treatment of symptomatic fibroids: a systematic review and metaanalysis. Am J Obstet Gynecol. 2011;205(4):317 e1–18.\nKim HS et al. MR-guided high-intensity focused ultrasound treatment for symptomatic uterine leiomyomata: long-term outcomes. Acad Radiol. 2011;18(8):970–6.\nFunaki K, Fukunishi H, Sawada K. Clinical outcomes of magnetic resonance-guided focused ultrasound surgery for uterine myomas: 24-month follow-up. Ultrasound Obstet Gynecol. 2009;34(5):584–9.\nRCoOa G. Preventing entry-related gynaecological laparoscopic injuries. RCOG Green-top Guideline. 2008;49:1–10.\nWallach EE, Vlahos NF. Uterine myomas: an overview of development, clinical features, and management. Obstet Gynecol. 2004;104(2):393–406.\nKim MS et al. Obstetric outcomes after uterine myomectomy: laparoscopic versus laparotomic approach. Obstet Gynecol Sci. 2013;56(6):375–81.\nLonnerfors C, Persson J. Pregnancy following robot-assisted laparoscopic myomectomy in women with deep intramural myomas. Acta Obstet Gynecol Scand. 2011;90(9):972–7.\nMettler L et al. Complications of uterine fibroids and their management, surgical management of fibroids, laparoscopy and hysteroscopy versus hysterectomy, haemorrhage, adhesions, and complications. Obstet Gynecol Int. 2012;2012:791248.\nDi Spiezio Sardo A et al. Hysteroscopic myomectomy: a comprehensive review of surgical techniques. Hum Reprod Update. 2008;14(2):101–19.\nEmanuel MH et al. An analysis of fluid loss during transcervical resection of submucous myomas. Fertil Steril. 1997;68(5):881–6.\nWamsteker K, Emanuel MH, de Kruif JH. Transcervical hysteroscopic resection of submucous fibroids for abnormal uterine bleeding: results regarding the degree of intramural extension. Obstet Gynecol. 1993;82(5):736–40.\nHart R, Molnar BG, Magos A. Long term follow up of hysteroscopic myomectomy assessed by survival analysis. Br J Obstet Gynaecol. 1999;106(7):700–5.\nMettler L et al. Imaging in gynecologic surgery. Womens Health (Lond Engl). 2011;7(2):239–48. quiz 249–50.\nVarma R et al. Hysteroscopic myomectomy for menorrhagia using Versascope bipolar system: efficacy and prognostic factors at a minimum of one year follow up. Eur J Obstet Gynecol Reprod Biol. 2009;142(2):154–9.\nLoffer FD et al. Hysteroscopic fluid monitoring guidelines. The ad hoc committee on hysteroscopic training guidelines of the American Association of Gynecologic Laparoscopists. J Am Assoc Gynecol Laparosc. 2000;7(1):167–8.\nJansen FW et al. Complications of hysteroscopy: a prospective, multicenter study. Obstet Gynecol. 2000;96(2):266–70.\nPropst AM et al. Complications of hysteroscopic surgery: predicting patients at risk. Obstet Gynecol. 2000;96(4):517–20.\nParker WH, Rodi IA. Patient selection for laparoscopic myomectomy. J Am Assoc Gynecol Laparosc. 1994;2(1):23–6.\nLefebvre G et al. The management of uterine leiomyomas. J Obstet Gynaecol Can. 2003;25(5):396–418. quiz 419–22.\nAlkatout I et al. Precarious preoperative diagnostics and hints for the laparoscopic excision of uterine adenomatoid tumors: two exemplary cases and literature review. Fertil Steril. 2011;95(3):1119 e5–8.\nDueholm M et al. Accuracy of magnetic resonance imaging and transvaginal ultrasonography in the diagnosis, mapping, and measurement of uterine myomas. Am J Obstet Gynecol. 2002;186(3):409–15.\nAlkatout I et al. Principles and safety measures of electrosurgery in laparoscopy. JSLS. 2012;16(1):130–9.\nAlkatout I et al. Organ-preserving management of ovarian pregnancies by laparoscopic approach. Fertil Steril. 2011;95(8):2467–70. e1–2.\nKongnyuy EJ, Wiysonge CS. Interventions to reduce haemorrhage during myomectomy for fibroids. Cochrane Database Syst Rev. 2011;11:CD005355.\nZhao F et al. Evaluation of loop ligation of larger myoma pseudocapsule combined with vasopressin on laparoscopic myomectomy. Fertil Steril. 2010;95(2):762–6.\nTinelli A et al. Impact of surgical approach on blood loss during intracapsular myomectomy. Minim Invasive Ther Allied Technol. 2013;23(2):87–95.\nCelik H, Sapmaz E. Use of a single preoperative dose of misoprostol is efficacious for patients who undergo abdominal myomectomy. Fertil Steril. 2003;79(5):1207–10.\nMettler L et al. Cross-linked sodium hyaluronate, an anti-adhesion barrier gel in gynaecological endoscopic surgery. Minim Invasive Ther Allied Technol. 2013;22(5):260–5.\nMettler L, Schollmeyer T, Alkatout I. Adhesions during and after surgical procedures, their prevention and impact on women’s health. Womens Health (Lond Engl). 2012;8(5):495–8.\nTulandi T, Murray C, Guralnick M. Adhesion formation and reproductive outcome after myomectomy and second-look laparoscopy. Obstet Gynecol. 1993;82(2):213–5.\nTsuji S et al. MRI evaluation of the uterine structure after myomectomy. Gynecol Obstet Invest. 2006;61(2):106–10.\nD’Angelo E, Prat J. Uterine sarcomas: a review. Gynecol Oncol. 2009;116(1):131–9.\nMukhopadhaya N, De Silva C, Manyonda IT. Conventional myomectomy. Best Pract Res Clin Obstet Gynaecol. 2008;22(4):677–705.\nDiscepola F et al. Analysis of arterial blood vessels surrounding the myoma: relevance to myomectomy. Obstet Gynecol. 2007;110(6):1301–3.\nPundir J et al. Robotic-assisted laparoscopic vs abdominal and laparoscopic myomectomy: systematic review and meta-analysis. J Minim Invasive Gynecol. 2013;20(3):335–45.\nBarakat EE et al. Robotic-assisted, laparoscopic, and abdominal myomectomy: a comparison of surgical outcomes. Obstet Gynecol. 2011;117(2 Pt 1):256–65.\nMettler L et al. The past, present and future of minimally invasive endoscopy in gynecology: a review and speculative outlook. Minim Invasive Ther Allied Technol. 2013;22(4):210–26.\nSchollmeyer T et al. Roboterchirurgie in der Gynäkologie. Gynakologe. 2011;44(3):196–201.\nGeorge A, Eisenstein D, Wegienka G. Analysis of the impact of body mass index on the surgical outcomes after robot-assisted laparoscopic myomectomy. J Minim Invasive Gynecol. 2009;16(6):730–3.\nFalcone T, Parker WH. Surgical management of leiomyomas for fertility or uterine preservation. Obstet Gynecol. 2013;121(4):856–68.\nGarry R et al. EVALUATE hysterectomy trial: a multicentre randomised trial comparing abdominal, vaginal and laparoscopic methods of hysterectomy. Health Technol Assess. 2004;8(26):1–154.\nAdashi EY. The climacteric ovary as a functional gonadotropin-driven androgen-producing gland. Fertil Steril. 1994;62(1):20–7.\nShifren JL. The role of androgens in female sexual dysfunction. Mayo Clin Proc. 2004;79(4 Suppl):S19–24.\nBuster JE et al. Testosterone patch for low sexual desire in surgically menopausal women: a randomized trial. Obstet Gynecol. 2005;105(5 Pt 1):944–52.\nNyunt A et al. Androgen status in healthy premenopausal women with loss of libido. J Sex Marital Ther. 2005;31(1):73–80.\nManson JE et al. Estrogen plus progestin and the risk of coronary heart disease. N Engl J Med. 2003;349(6):523–34.\nAnderson GL et al. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women’s Health Initiative randomized controlled trial. JAMA. 2004;291(14):1701–12.\nParker WH et al. Ovarian conservation at the time of hysterectomy for benign disease. Obstet Gynecol. 2005;106(2):219–26.\nDietl J, Wischhusen J, Hausler SF. The post-reproductive Fallopian tube: better removed? Hum Reprod. 2011;26(11):2918–24.\nGuldberg R et al. Salpingectomy as standard at hysterectomy? A Danish cohort study, 1977–2010. BMJ Open. 2013;3(6):e002845.\nAAMIG W. AAGL position statement: Robotic-assisted laparoscopic surgery in benign gynecology. J Minim Invasive Gynecol. 2013;20(1):2–9.\nMeeks GR, Harris RL. Surgical approach to hysterectomy: abdominal, laparoscopy-assisted, or vaginal. Clin Obstet Gynecol. 1997;40(4):886–94.\nMazdisnian F et al. Vaginal hysterectomy by uterine morcellation: an efficient, non-morbid procedure. Obstet Gynecol. 1995;86(1):60–4.\nJenkins TR. Laparoscopic supracervical hysterectomy. Am J Obstet Gynecol. 2004;191(6):1875–84.\nBerner E et al. Pelvic pain and patient satisfaction after laparoscopic supracervical hysterectomy: prospective trial. J Minim Invasive Gynecol. 2013;21(3):406–11.\nAlkatout I et al. Combined surgical and hormone therapy for endometriosis is the most effective treatment: prospective, randomized, controlled trial. J Minim Invasive Gynecol. 2013;20(4):473–81.\nSemm K. Hysterectomy via laparotomy or pelviscopy. A new CASH method without colpotomy. Geburtshilfe Frauenheilkd. 1991;51(12):996–1003.\nAcknowledgement\nThe authors thank Nicole Guckelsberger and Dawn Rüther for editing the manuscript.\nAuthor information\nAuthors and Affiliations\nCorresponding author\nEditor information\nEditors and Affiliations\nRights and permissions\nCopyright information\n© 2018 Springer International Publishing Switzerland\nAbout this chapter\nCite this chapter\nMettler, L., Alkatout, I. (2018). Symptomatic Fibroids as Main Indication for Laparoscopic Hysterectomy and Their Handling. In: Alkatout, I., Mettler, L. (eds) Hysterectomy. Springer, Cham. https://doi.org/10.1007/978-3-319-22497-8_30\nDownload citation\nDOI: https://doi.org/10.1007/978-3-319-22497-8_30\nPublished:\nPublisher Name: Springer, Cham\nPrint ISBN: 978-3-319-22496-1\nOnline ISBN: 978-3-319-22497-8\neBook Packages: MedicineMedicine (R0)","source_license":"CC0","license_restricted":false}